What's new at Łukasiewicz – PORT?
- Reading time: 4 min.
Medicine still lacks sufficiently effective tools that would allow for fast and accurate diagnosis of patients with neuropsychiatric disorders. For this reason, scientists at Łukasiewicz – PORT aim to better understand the abnormalities in brain function that lead to these conditions.
- Reading time: 3 min.
Which skills will be crucial in the coming decades? How is artificial intelligence changing the labor market and the role of leaders?
- Reading time: 4 min.
On 06/02/2025, the European Commission, together with the European Society of Radiology (ESR) and the European Federation for Cancer Images (EUCAIM), brought together 160 leading experts from policy-making, research, healthcare, and industry to explore how the European Cancer Imaging Initiative leverages health data and artificial intelligence to improve cancer detection and treatment.
- Reading time: 4 min.
The team led by Dr. Heng-Chang Chen from Łukasiewicz – PORT, in collaboration with scientists from Jagiellonian University and KU Leuven (Belgium), has set out to identify innovative strategies for the functional cure of HIV. The research has received PLN 3.5 million in funding from the Weave-U NISONO program.
- Reading time: 1 min.
We invite our research groups to participate in the “Commercialisation Ideation Workshop”, organized as part of the SAME-NeuroID – Senior Staff Training project, in cooperation with the Technology Transfer Office of Łukasiewicz – PORT. The workshop will take place on Wednesday, 26 February, and will be led by the Biocatalyst Foundation—a non-profit organization that supports the development of the biotechnology community and facilitates networking and international collaboration.
- Reading time: 2 min.
Seven Wrocław-based scientific institutions are consolidating their efforts to jointly build a strong research and development ecosystem and strengthen the city’s position as a major scientific center. This marks the first step toward establishing a Wrocław-based center of excellence.
- Reading time: 3 min.
Dr hab. Grzegorz Chodaczek, leader of the Immunotherapy Research Group at Łukasiewicz – PORT, demonstrates that appropriately selected gamma-delta T lymphocytes obtained from human blood may constitute an effective tool in the fight against the most aggressive brain tumor – glioblastoma multiforme. Nearly PLN 15 million granted to the Wrocław-based researchers by the Medical Research Agency (ABM) will enable the continuation of studies aimed at developing an innovative anticancer therapy based on human immune cells.
- Reading time: 3 min.
Łukasiewicz – PORT Polish Centre for Technology Development invites you to a lecture by Prof. Agnieszka Chacińska, group leader and Director of IMol – the International Institute of Molecular Mechanisms and Machines of the Polish Academy of Sciences.
- Reading time: 6 min.
Dr. Marek Wagner, Head of the Innate Immunity Research Group at Łukasiewicz – PORT, has achieved something that is rare in Polish science (and beyond) and a dream of every scientist. He has just published an article in Nature, one of the most prestigious scientific journals in the world. In the paper, he presents, among other findings, the results of his research on ILC2 immune cells, demonstrating that cells previously known mainly for inducing type 2 immune responses associated with protection against parasites may also play a key role in the fight against cancer.
- Reading time: 2 min.
Łukasiewicz – PORT Polish Center for Technology Development invites you to a lecture by Dr. Nikolas Karalis, Team Leader at the Paris Brain Institute (Institut du Cerveau – ICM), France.
